Tenderwize
Back to tender search

Open House Discount Agreements for Sunitinib, ATC L01EX01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sunitinib, ATC L01EX01

30/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

30 / 100

Complexity

40 / 100

Risk factors

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive pharmaceutical discount agreements for Sunitinib (ATC L01EX01)
  • Open house model with uniform terms for all participants
Show full summary

Open house non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active ingredient Sunitinib (ATC L01EX01) with the AOK Rheinland-Pfalz/Saarland. The open house model allows any interested pharmaceutical company to conclude a contract without a competitive selection process. The maximum contract duration is 24 months, with the earliest start on 01.06.2025 and all contracts ending by 31.05.2027. Contracts can be joined monthly. The buyer reserves the right to replace open house contracts with exclusive contracts awarded through EU-wide tenders. The notice states it is not a formal public procurement under EU directives, but published voluntarily for transparency.

Risks

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorized and marketable drugs in Germany (verified via Lauer-Taxe or AMIce database)
  • Proof of marketing authorization and pharmaceutical entrepreneur status

Administrative

  • Submission of signed contract documents by the deadline

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreements for Sunitinib, ATC L01EX01

Non-exclusive discount agreements for Sunitinib drugs. All interested pharmaceutical companies can participate. Contract terms are uniform, no individual negotiations. First contract start on 01.06.2025, initial submission deadline 30.04.2025. Later contracts possible monthly until 31.03.2027. The open house agreements may be terminated early if the buyer concludes exclusive contracts.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235482-2025

Documents (1)

Similar tenders